| GlaxoSmithKline AG - Priorix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 00615 | | 01 | | Priorix | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | J07BD52 | | Measles, Combinations with Mumps and Rubella, Live Attenuated | | 22.12.1998 | | |
| | Composition | | Praeparatio cryodesiccata: virus morbilli vivus (Stamm Schwarz) min. 1000 U., virus parotitis vivus (Stamm RIT 4385) min. 5000 U., virus rubella vivus (Stamm Wistar RA 27/3) min. 1000 U., lactosum, sorbitolum 9 mg, mannitolum, aminoacida cum phenylalaninum 334 µg, pro vitro, residui: neomycini sulfas.
Solvens: aqua ad iniectabile. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Virus Morbilli Vivus (Stamm Schwarz) | 1000 U | | Virus Parotitis Vivus (Stamm: rit 4385) | 5000 U | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
| | BAG: Active Agent | Dose |
|---|
| Vaccinum Morbillorum Vivum | | | Vaccinum Parotitidis Vivum | | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
| | | | Inactive agents | Dose |
|---|
| Aminoacida cum Phenylalaninum | 334 µg | | Lactosum | | | Mannitol | | | Sorbitol | 9 mg |
| |
| Solvens | | | aqua ad iniectabile | | | | | | BAG: Active Agent | Dose |
|---|
| Vaccinum Morbillorum Vivum | | | Vaccinum Parotitidis Vivum | | | Virus Rubella Vivus (Stamm Wistar ra 27/3) | 1000 U |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Kombipackung(en) | 17.57 | 35.50 | B | SL | Yes | | 002 | 10 Kombipackung(en) | PR | PR | B | | Yes |
|
|
